FUNI · Hypha Labs, Inc.
$0.01
+0.00 (+3.33%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, our balance of cash on hand was $5,110, and we had negative working capital of $1,577,350 and an accumulated deficit of $24,996,836 resulting from recurring losses. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.52M
Shares
163.90M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.7M
+7.8%
FY2022
Net Income
-$3.1M
-294.9%
FY2025
Gross Margin
39.48%
+10.9pp
FY2022
Operating Margin
-42.61%
-11.8pp
FY2022
Diluted EPS
-$0.02
-100%
FY2025
Operating Cash Flow
-$379.98K
+63.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.73M | — | — | — | $2.7M | $2.5M | $2.57M | $2.55M | $2.84M | $1.9M | $818.58K | $16.08K | $54.94K | $567.19K | $391.7K | $95.91K | |
| — | — | — | — | $63.09K | $930 | — | — | — | — | — | — | — | — | — | — | |
| $1.63M | — | — | — | $1.63M | $1.79M | $1.78M | $1.71M | $2.07M | $904.17K | $380.04K | $85.55K | $29.27K | $303.95K | $222.22K | $0 | |
| $1.09M | — | — | — | $1.07M | $715.17K | $795.84K | $839.81K | $770.08K | $994.01K | $438.55K | -$69.47K | $25.67K | $263.24K | $169.48K | $95.91K | |
| — | — | — | — | 39.48% | 28.56% | 30.91% | 32.9% | 27.12% | 52.37% | 53.57% | -431.9% | 46.72% | 46.41% | 43.27% | 100% | |
| — | — | — | — | — | — | — | — | — | — | — | $143.77K | $23.13K | — | — | — | |
| $551.12K | $1.42M | $943.69K | $103.3K | $495.76K | $934.14K | $1.48M | $1.67M | $2.06M | $1.26M | $1.26M | $1.56M | $2.34M | $574.82K | $479.15K | $113.03K | |
| $22.21K | — | — | — | — | — | $20.22K | — | — | — | — | — | — | — | — | — | |
| $181.44K | — | — | — | $204.15K | $292.13K | $323.39K | $260.65K | $277.29K | $253.54K | $244.58K | $83.73K | $4586 | — | — | — | |
| $1.48M | $3M | $1.83M | $437.39K | $1.15M | $1.49M | $2.99M | $2.68M | $2.53M | $2.29M | $3.32M | $3.37M | $2.36M | — | — | — | |
| -$1.48M | -$3M | -$1.83M | -$437.39K | -$1.15M | -$772.45K | -$2.19M | -$1.84M | -$1.76M | -$1.3M | -$2.88M | -$3.44M | -$2.34M | -$311.58K | -$309.67K | -$17.12K | |
| — | — | — | — | -42.61% | -30.85% | -85.16% | -72.21% | -61.93% | -68.34% | -352.13% | -21396.75% | -4252.03% | -54.93% | -79.06% | -17.85% | |
| -$858.77K | — | — | — | -$946.31K | -$480.32K | -$1.87M | -$1.58M | -$1.48M | -$1.04M | -$2.64M | -$3.36M | -$2.33M | — | — | — | |
| $336.96K | $106.14K | $201.77K | $364.27K | $244.59K | $144.96K | $148.02K | $65.67K | — | — | — | — | — | $18.06K | $16.02K | $10.43K | |
| — | — | — | — | — | — | — | — | — | $10K | $10K | — | — | — | — | — | |
| -$423.6K | -$100.49K | $470.63K | -$244.27K | -$1.03M | $85.95K | -$117.11K | $37.81K | $105.11K | $232.07K | -$816.55K | -$272.3K | -$11.64K | — | — | — | |
| -$1.91M | -$3.1M | -$1.36M | -$681.66K | — | — | — | — | — | — | — | — | -$2.83M | -$329.65K | — | — | |
| — | — | $14.19K | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | |
| -$1.91M | -$3.1M | -$785.43K | $246.77K | -$2.06M | -$686.5K | -$2.31M | -$1.81M | -$1.65M | -$1.07M | -$3.7M | -$4.33M | -$2.83M | -$329.65K | -$325.69K | -$27.55K | |
| — | — | — | — | -76.19% | -27.42% | -89.71% | -70.73% | -58.23% | -56.11% | -451.88% | -26935.64% | -5154.99% | -58.12% | -83.15% | -28.72% | |
| — | — | — | — | — | — | — | — | — | — | $3.7M | $3.71M | — | — | — | — | |
| — | — | — | $246.77K | -$2.25M | -$686.5K | — | — | — | — | — | — | — | — | — | — | |
| -$1.68M | — | — | — | — | — | — | — | — | -$1.07M | -$3.7M | -$4.37M | -$2.83M | — | — | — | |
| USD/shares | -$0.01 | -$0.02 | -$0.01 | $0.00 | -$0.03 | -$0.01 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | -$0.01 | -$0.02 | -$0.01 | $0.00 | -$0.03 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 135.15M | 101.35M | 83.93M | 74.17M | 65.87M | 53.46M | 46.18M | 39.08M | 29.32M | 18.44M | 9.91M | -0.96 | 5.53M | 5.47M | — |
| shares | — | 135.15M | 101.35M | 83.93M | 74.17M | 65.87M | 53.46M | 46.18M | 39.08M | 29.32M | 18.44M | 9.91M | -0.96 | 5.53M | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Diagnostics & Research median 5.34×
EV/EBIT
—
Diagnostics & Research median 32.97×
P/E (TTM)
—
Diagnostics & Research median 33.47×